0001203311-23-000058.txt : 20230602
0001203311-23-000058.hdr.sgml : 20230602
20230602181940
ACCESSION NUMBER: 0001203311-23-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230531
FILED AS OF DATE: 20230602
DATE AS OF CHANGE: 20230602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SWAIN SANDRA M
CENTRAL INDEX KEY: 0001908755
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23990582
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-05-31
0
0001060736
Seagen Inc.
SGEN
0001908755
SWAIN SANDRA M
21823 30TH DRIVE S.E.
BOTHELL
WA
98021
1
0
0
0
0
Common Stock
2023-05-31
4
A
0
2044
0.0
A
2822
D
These securities are restricted stock units and will be settled in common stock upon vesting.
These restricted stock units shall vest in full on May 31, 2024.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Jennifer Prosba For: Sandra Swain
2023-06-02